Linking covalent histone modifications to epigenetics: The rigidity and plasticity of the marks

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 69, Issue , 2004, Pages 161-169

  Wang, Y ^a,b   Wysocka, J ^a,b   Perlin, J R ^a   Leonelli, L ^a   Allis, C D ^b   Coonrod, S A ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; DNA; HISTONE; LYSINE; PROTEIN METHYLTRANSFERASE; HISTONE METHYLTRANSFERASE;

CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL REGENERATION; CHROMATIN; CONFERENCE PAPER; DNA METHYLATION; DNA MODIFICATION; EMBRYO DEVELOPMENT; EPIGENETICS; GENE EXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC REGULATION; GENETIC TRAIT; GERM CELL; MALIGNANT NEOPLASTIC DISEASE; MAMMAL; MAMMALIAN GENETICS; MOLECULAR CLONING; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; RIGIDITY; SIGNAL TRANSDUCTION; ARTICLE; CELL DEDIFFERENTIATION; CELL PLASTICITY; COVALENT BOND; GENOME IMPRINTING; GERM LAYER; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; ORGANOGENESIS;

AMIDOHYDROLASES; AMINO ACID SEQUENCE; ANIMALS; CELL DIFFERENTIATION; CHROMATIN; CLONING, ORGANISM; EMBRYONIC DEVELOPMENT; EPIGENESIS, GENETIC; FEMALE; GERM CELLS; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; HYDROLASES; METHYLATION; MICE; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; NEOPLASMS; PREGNANCY;

MAMMALIA;

EID: 23044500926     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2004.69.161     Document Type: Conference Paper

References (78)

1. Agalioti T., Chen G., and Thanos D. 2002. Deciphering the transcriptional histone acetylation code for a human gene. Cell 111: 381.
2. Ahmad K. and Henikoff S. 2002. The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly. Mol. Cell 9: 1191.
3. An W., Kim J., and Roeder R.G. 2004. Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional activation of p53. Cell 117: 735.
4. Bachman K.E., Park B.H., Rhee I., Rajagopalan H., Herman J.G., Baylin S.B., Kinzler K.W., and Vogelstein B. 2003. Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer Cell 3: 89.
5. Bannister A.J., Schneider R., and Kouzarides T. 2002. Histone methylation: Dynamic or static? Cell 109: 801.
6. Bannister A.J., Zegerman P., Partridge J.F., Miska E.A., Thomas J.O., Allshire R.C., and Kouzarides T. 2001. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410: 120.
7. Bauer U.M., Daujat S., Nielsen S.J., Nightingale K., and Kouzarides T. 2002. Methylation at arginine 17 of histone H3 is linked to gene activation. EMBO Rep. 3: 39.
8. Boger R.H. 2003. Asymmetric dimethylarginine ADMA modulates endothelial function-therapeutic implications. Vasc. Med. 8: 149.
9. Campbell K.H., McWhir J., Ritchie W.A., and Wilmut I. 1996. Sheep cloned by nuclear transfer from a cultured cell line. Nature 380: 64.
10. Cavalli G. and Paro R. 1999. Epigenetic inheritance of active chromatin after removal of the main transactivator. Science 286: 955.
11. Cheung P., Allis C.D., and Sassone-Corsi P. 2000. Signaling to chromatin through histone modifications. Cell 103: 263.
12. Daujat S., Bauer U.M., Shah V., Turner B., Berger S., and Kouzarides T. 2002. Crosstalk between CARM1 methylation and CBP acetylation on histone H3. Curr. Biol. 12: 2090.
13. De Keyser J., Schaaf M., and Teelken A. 1999. Peptidylarginine deiminase activity in postmortem white matter of patients with multiple sclerosis. Neurosci. Lett. 260: 74.
14. Dodge J.E., Kang Y.K., Beppu H., Lei H., and Li E. 2004. Histone H3-K9 methyltransferase ESET is essential for early development. Mol. Cell. Biol. 24: 2478.
15. Eggan K., Baldwin K., Tackett M., Osborne J., Gogos J., Chess A., Axel R., and Jaenisch R. 2004. Mice cloned from olfactory sensory neurons. Nature 428: 44.
16. Erhardt S., Su I.H., Schneider R., Barton S., Bannister A.J., Perez-Burgos L., Jenuwein T., Kouzarides T., Tarakhovsky A., and Surani M.A. 2003. Consequences of the depletion of zygotic and embryonic enhancer of zeste 2 during preimplantation mouse development. Development 130: 4235.
17. Feinberg A.P. and Tycko B. 2004. The history of cancer epigenetics. Nat. Rev. Cancer 4: 143.
18. Felsenfeld G. and Groudine M. 2003. Controlling the double helix. Nature 421: 448.
19. Fenaux P., Castaigne S., Dombret H., Archimbaud E., Duarte M., Morel P., Lamy T., Tilly H., Guerci A., and Maloisel F., et al. 1992. All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: A pilot study on 26 cases. Blood 80: 2176.
20. Fischle W., Wang Y., and Allis C.D. 2003. Binary switches and modification cassettes in histone biology and beyond. Nature 425: 475.
21. Fuks F., Hurd P.J., Wolf D., Nan X., Bird A.P., and Kouzarides T. 2003. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 278: 4035.
22. Grunstein M. 1997. Histone acetylation in chromatin structure and transcription. Nature 389: 349.
23. Hagiwara T., Nakashima K., Hirano H., Senshu T., and Yamada M. 2002. Deimination of arginine residues in nucleophosmin/ B23 and histones in HL-60 granulocytes. Biochem. Biophys. Res. Commun. 290: 979.
24. Hajkova P., Erhardt S., Lane N., Haaf T., El-Maarri O., Reik W., Walter J., and Surani M.A. 2002. Epigenetic reprogramming in mouse primordial germ cells. Mech. Dev. 117: 15.
25. Hiendleder S., Mund C., Reichenbach H.D., Wenigerkind H., Brem G., Zakhartchenko V., Lyko F., and Wolf E. 2004. Tissue-specific elevated genomic cytosine methylation levels are associated with an overgrowth phenotype of bovine fetuses derived by in vitro techniques. Biol. Reprod. 71: 217.
26. Huang S. 2002. Histone methyltransferases, diet nutrients and tumor suppressors. Nat. Rev. Cancer 2: 469.
27. Jackson J.P., Lindroth A.M., Cao X., and Jacobsen S.E. 2002. Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature 416: 556.
28. Jaenisch R. and Bird A. 2003. Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nat. Genet. (suppl.) 33: 245.
29. Janicki S.M., Tsukamoto T., Salghetti S.E., Tansey W.P., Sachidanandam R., Prasanth K.V., Ried T., Shav-Tal Y., Bertrand E., Singer R.H., and Spector D.L. 2004. From silencing to gene expression: Real-time analysis in single cells. Cell 116: 683.
30. Jenuwein T. and Allis C.D. 2001. Translating the histone code. Science 293: 1074.
31. Kelley R.L., Wang J., Bell L., and Kuroda M.I. 1997. Sex lethal controls dosage compensation in Drosophila by a non-splicing mechanism. Nature 387: 195.
32. Kelly T.L. and Trasler J.M. 2004. Reproductive epigenetics. Clin. Genet. 65: 247.
33. Khorasanizadeh S. 2004. The nucleosome: From genomic organization to genomic regulation. Cell 116: 259.
34. Kim J.H., Yoon S.Y., Kim C.N., Joo J.H., Moon S.K., Choe I.S., Choe Y.K., and Kim K.C., Geng L., and Huang S. 2003. Inactivation of a histone methyltransferase by mutations in human cancers. Cancer Res. 63: 7619.
35. Kouzarides T. 2002. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev. 12: 198.
36. Kurdistani S.K., Tavazoie S., and Grunstein M. 2004. Mapping global histone acetylation patterns to gene expression. Cell 117: 721.
37. Lachner M., O'Sullivan R.J., and Jenuwein T. 2003. An epigenetic road map for histone lysine methylation. J. Cell Sci. 116: 2117.
38. Lee J., Inoue K., Ono R., Ogonuki N., Kohda T., Kaneko-Ishino T., Ogura A., and Ishino F. 2002. Erasing genomic imprinting memory in mouse clone embryos produced from day 11.5 primordial germ cells. Development 129: 1807.
39. Lessard J. and Sauvageau G. 2003. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 423: 255.
40. Li E. 2002. Chromatin modification and epigenetic reprogramming in mammalian development. Nat. Rev. Genet. 3: 662.
41. Luger K., Mader A.W., Richmond R.K., Sargent D.F., and Richmond T.J. 1997. Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389: 251.
42. Matzuk M.M. and Lamb D.J. 2002. Genetic dissection of mammalian fertility pathways. Nat. Cell Biol. (suppl.) 4: s41.
43. Mayer W., Niveleau A., Walter J., Fundele R., and Haaf T. 2000. Demethylation of the zygotic paternal genome. Nature 403: 501.
44. Milne T.A., Briggs S.D., Brock H.W., Martin M.E., Gibbs D., Allis C.D., and Hess J.L. 2002. MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol. Cell 10: 1107.
45. Molofsky A.V., Pardal R., Iwashita T., Park I.K., Clarke M.F., and Morrison S.J. 2003. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 425: 962.
46. Nakamura T., Mori T., Tada S., Krajewski W., Rozovskaia T., Wassell R., Dubois G., Mazo A., Croce C.M., and Canaani E. 2002. ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol. Cell 10: 1119.
47. Ogawa T., Kimoto M., and Sasaoka K. 1989. Purification and properties of a new enzyme, NG,NG-dimethylarginine dimethylaminohydrolase, from rat kidney. J. Biol. Chem. 264: 10205.
48. Okamoto I., Otte A.P., Allis C.D., Reinberg D., and Heard E. 2004. Epigenetic dynamics of imprinted X inactivation during early mouse development. Science 303: 644.
49. Park Y. and Kuroda M.I. 2001. Epigenetic aspects of X-chromosome dosage compensation. Science 293: 1083.
50. Peters A.H., O'Carroll D., Scherthan H., Mechtler K., Sauer S., Schofer C., Weipoltshammer K., Pagani M., Lachner M., Kohlmaier A., Opravil S., Doyle M., Sibilia M., and Jenuwein T. 2001. Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 107: 323.
51. Roth S.Y., Denu J.M., and Allis C.D. 2001. Histone acetyltransferases. Annu. Rev. Biochem. 70: 81.
52. Santos-Rosa H., Schneider R., Bernstein B.E., Karabetsou N., Morillon A., Weise C., Schreiber S.L., Mellor J., and Kouzarides T. 2003. Methylation of histone H3 K4 mediates association of the Isw1p ATPase with chromatin. Mol. Cell 12: 1325.
53. Sarmento O.F., Digilio L.C., Wang Y., Perlin J., Herr J.C., Allis C.D., and Coonrod S.A. 2004. Dynamic alterations of specific histone modifications during early murine development. J. Cell Sci. 117: 4449.
54. Sassone-Corsi P. 2002. Unique chromatin remodeling and transcriptional regulation in spermatogenesis. Science 296: 2176.
55. Schreiber S.L. and Bernstein B.E. 2002. Signaling network model of chromatin. Cell 111: 771.
56. Schubeler D., MacAlpine D.M., Scalzo D., Wirbelauer C., Kooperberg C., van Leeuwen F., Gottschling D.E., O'Neill L.P., Turner B.M., Delrow J., Bell S.P., and Groudine M. 2004. The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev. 18: 1263.
57. Shiio Y. and Eisenman R.N. 2003. Histone sumoylation is associated with transcriptional repression. Proc. Natl. Acad. Sci. 100: 13225.
58. Simon J.A. and Tamkun J.W. 2002. Programming off and on states in chromatin: Mechanisms of Polycomb and trithorax group complexes. Curr. Opin. Genet. Dev. 12: 210.
59. Soppe W.J., Jasencakova Z., Houben A., Kakutani T., Meister A., Huang M.S., Jacobsen S.E., Schubert I., and Fransz P.F. 2002. DNA methylation controls histone H3 lysine 9 methylation and heterochromatin assembly in Arabidopsis. EMBO J. 21: 6549.
60. Steele-Perkins G., Fang W., Yang X.H., Van Gele M., Carling, T., Gu J., Buyse I.M., Fletcher J.A., Liu J., Bronson R., Chadwick R.B., de la Chapelle A., Zhang X., Speleman F., and Huang S. 2001. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev. 15: 2250.
61. Strahl B.D. and Allis C.D. 2000. The language of covalent histone modifications. Nature 403: 41.
62. Strahl B.D., Ohba R., Cook R.G., and Allis C.D. 1999. Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc. Natl. Acad. Sci. 96: 14967.
63. Strahl B.D., Briggs S.D., Brame C.J., Caldwell J.A., Koh S.S., Ma H., Cook R.G., Shabanowitz J., Hunt D.F., Stallcup M.R., and Allis C.D. 2001. Methylation of histone H4 at arginine 3 occurs in vivo and is mediated by the nuclear receptor coactivator PRMT1. Curr. Biol. 11: 996.
64. Strukov Y.G., Wang Y., and Belmont A.S. 2003. Engineered chromosome regions with altered sequence composition demonstrate hierarchical large-scale folding within metaphase chromosomes. J. Cell Biol. 162: 23.
65. Suzuki A., Yamada R., Chang X., Tokuhiro S., Sawada T., Suzuki M., Nagasaki M., Nakayama-Hamada M., Kawaida R., Ono M., Ohtsuki M., Furukawa H., Yoshino S., Yukioka M., Tohma S., Matsubara T., Wakitani S., Teshima R., Nishioka Y., Sekine A., Iida A., Takahashi A., Tsunoda T., Nakamura Y., and Yamamoto K. 2003. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 34: 395.
66. Tagami H., Ray-Gallet D., Almouzni G., and Nakatani Y. 2004. Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell 116: 51.
67. Tamaru H., Zhang X., McMillen D., Singh P.B., Nakayama J., Grewal S.I., Allis C.D., Cheng X., and Selker E.U. 2003. Trimethylated lysine 9 of histone H3 is a mark for DNA methylation in Neurospora crassa. Nat. Genet. 34: 75.
68. van Holde K.E. 1989. Chromatin. Springer-Verlag, New York.
69. van Kemenade F.J., Raaphorst F.M., Blokzijl T., Fieret E., Hamer K.M., Satijn D.P., Otte A.P., and Meijer C.J. 2001. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood 97: 3896.
70. Varambally S., Dhanasekaran S.M., Zhou M., Barrette T.R., Kumar-Sinha C., Sanda M.G., Ghosh D., Pienta K.J., Sewalt R.G., Otte A.P., Rubin M.A., and Chinnaiyan A.M. 2002. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419: 624.
71. Vossenaar E.R., Zendman A.J., van Venrooij W.J., and Pruijn G.J. 2003. PAD, a growing family of citrullinating enzymes: Genes, features and involvement in disease. Bioessays 25: 1106.
72. Wakayama T., Perry A.C., Zuccotti M., Johnson K.R., and Yanagimachi R. 1998. Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 394: 369.
73. Wang H., Huang Z.Q., Xia L., Feng Q., Erdjument-Bromage H., Strahl B.D., Briggs S.D., Allis C.D., Wong J., Tempst P., and Zhang Y. 2001. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293: 853.
74. Wolffe A. 1998. Chromatin. Academic Press, London.
75. Wolffe A.P. and Matzke M.A. 1999. Epigenetics: Regulation through repression. Science 286: 481.
76. Wright P.W., Bolling L.C., Calvert M.E., Sarmento O.F., Berkeley E.V., Shea M.C., Hao Z., Jayes F.C., Bush L.A., Shetty J., Shore A.N., Reddi P.P., Tung K.S., Samy E., Allietta M.M., Sherman N.E., Herr J.C., and Coonrod S.A. 2003. ePAD, an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to egg cytoplasmic sheets. Dev. Biol. 256: 73.
77. Xie H., Ye M., Feng R., and Graf T. 2004. Stepwise reprogramming of B cells into macrophages. Cell 117: 663.
78. Zhang Y. and Reinberg D. 2001. Transcription regulation by histone methylation: Interplay between different covalent modifications of the core histone tails. Genes Dev. 15: 2343.